Secor C - Search Results

1

Characterization and structure of the human lysine-2-oxoglutarate reductase domain, a novel therapeutic target for treatment of glutaric aciduria type 1.

Leandro J, Khamrui S, Suebsuwong C, Chen PJ, Secor C, Dodatko T, Yu C, Sanchez R, DeVita RJ, Houten SM, Lazarus MB. Leandro J, et al. Among authors: secor c. Open Biol. 2022 Sep;12(9):220179. doi: 10.1098/rsob.220179. Epub 2022 Sep 21. Open Biol. 2022. PMID: 36128717 Free PMC article.

2

Inhibition and Crystal Structure of the Human DHTKD1-Thiamin Diphosphate Complex.

Leandro J, Khamrui S, Wang H, Suebsuwong C, Nemeria NS, Huynh K, Moustakim M, Secor C, Wang M, Dodatko T, Stauffer B, Wilson CG, Yu C, Arkin MR, Jordan F, Sanchez R, DeVita RJ, Lazarus MB, Houten SM. Leandro J, et al. Among authors: secor c. ACS Chem Biol. 2020 Aug 21;15(8):2041-2047. doi: 10.1021/acschembio.0c00114. Epub 2020 Jul 9. ACS Chem Biol. 2020. PMID: 32633484 Free PMC article.

3

High-Resolution Structure and Inhibition of the Schizophrenia-Linked Pseudokinase ULK4.

Khamrui S, Ung PMU, Secor C, Schlessinger A, Lazarus MB. Khamrui S, et al. Among authors: secor c. J Am Chem Soc. 2020 Jan 8;142(1):33-37. doi: 10.1021/jacs.9b10458. Epub 2019 Dec 17. J Am Chem Soc. 2020. PMID: 31841327 Free PMC article.

4

Synthesis and Biological Validation of a Harmine-Based, Central Nervous System (CNS)-Avoidant, Selective, Human β-Cell Regenerative Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase A (DYRK1A) Inhibitor.

Kumar K, Wang P, Wilson J, Zlatanic V, Berrouet C, Khamrui S, Secor C, Swartz EA, Lazarus M, Sanchez R, Stewart AF, Garcia-Ocana A, DeVita RJ. Kumar K, et al. Among authors: secor c. J Med Chem. 2020 Mar 26;63(6):2986-3003. doi: 10.1021/acs.jmedchem.9b01379. Epub 2020 Feb 19. J Med Chem. 2020. PMID: 32003560 Free PMC article.

5

Structure-Activity Relationships and Biological Evaluation of 7-Substituted Harmine Analogs for Human β-Cell Proliferation.

Kumar K, Wang P, A Swartz E, Khamrui S, Secor C, B Lazarus M, Sanchez R, F Stewart A, DeVita RJ. Kumar K, et al. Among authors: secor c. Molecules. 2020 Apr 23;25(8):1983. doi: 10.3390/molecules25081983. Molecules. 2020. PMID: 32340326 Free PMC article.

6

Enrichment strategy and initial characterization of heterodimers enriched from a co-formulated cocktail of therapeutic antibodies against SARS-COV-2.

Liu S, Yan Y, Secor CM, Oberholtzer ZR, Skow DJ, Sheikh M, Moon Y, Fu Y, Sandu C, Wang S, Li N, Nguyen JB, Rosconi MP, Pyles EA. Liu S, et al. Among authors: secor cm. MAbs. 2024 Jan-Dec;16(1):2338301. doi: 10.1080/19420862.2024.2338301. Epub 2024 Apr 9. MAbs. 2024. PMID: 38591617 Free PMC article.

7

Mary Thompson: A Legacy of Hope.

Secor C. Secor C. J Christ Nurs. 2024 Jan-Mar 01;41(1):8. doi: 10.1097/CNJ.0000000000001126. J Christ Nurs. 2024. PMID: 38044507 No abstract available.

8

Choosing Who Writes Your Story.

Secor C. Secor C. J Christ Nurs. 2024 Jan-Mar 01;41(1):7. doi: 10.1097/CNJ.0000000000001145. J Christ Nurs. 2024. PMID: 38044506 No abstract available.

9

The Ministry of Presence.

Secor C. Secor C. J Christ Nurs. 2023 Apr-Jun 01;40(2):76. doi: 10.1097/CNJ.0000000000001049. J Christ Nurs. 2023. PMID: 36872530 No abstract available.

10

From Hurt to Healing.

Secor C. Secor C. J Christ Nurs. 2022 Jul-Sep 01;39(3):138. doi: 10.1097/CNJ.0000000000000980. J Christ Nurs. 2022. PMID: 35665411 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page